Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation (Q81481400)
Jump to navigation
Jump to search
scientific article published on 22 October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation |
scientific article published on 22 October 2007 |
Statements
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation (English)
José I Fernández-Montequín
Ena Infante-Cristiá
Carmen Valenzuela-Silva
Neobalis Franco-Pérez
William Savigne-Gutierrez
Heriberto Artaza-Sanz
Lourdes Morejón-Vega
Cecilio González-Benavides
Osvaldo Eliseo-Musenden
Elizeth García-Iglesias
Jorge Berlanga-Acosta
Ricardo Silva-Rodríguez
Blas Y Betancourt
Pedro A López-Saura
Cuban Citoprot-P Study Group
22 October 2007